MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Roberto Dinami,
Luca Pompili,
Eleonora Petti,
Manuela Porru,
Carmen D'Angelo,
Serena Di Vito,
Angela Rizzo,
Virginia Campani,
Giuseppe De Rosa,
Alejandra Bruna,
Violeta Serra,
Miguel Mano,
Mauro Giacca,
Carlo Leonetti,
Gennaro Ciliberto,
Madalena Tarsounas,
Antonella Stoppacciaro,
Stefan Schoeftner,
Annamaria Biroccio
Nov 25, 2022
The telomeric repeat-binding factor 2 (TRF2) is a telomere-capping protein that plays a key role in the maintenance of telomere structure and function. It is highly expressed in different cancer types, and it contributes to...